Medi-Caps Ltd.

NSE: MEDICAPS BSE: 523144 SECTOR: Chemicals  9112   68   11

45.40
+0.05 (0.11%)
BSE: Today, 01:50 PM

Price Summary

Today's High

₹ 46

Today's Low

₹ 44.55

52 Week High

₹ 91.15

52 Week Low

₹ 0

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

56.61 Cr.

Enterprise Value

55.89 Cr.

No. of Shares

1.25 Cr.

P/E

0

P/B

0.93

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  49.05

CASH

0.73 Cr.

DEBT

0 Cr.

Promoter Holding

50.13 %

EPS (TTM)

₹  -0.06

Sales Growth

-93.2%

ROE

-0.18 %

ROCE

-0.19%

Profit Growth

98.67 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-93.2%
3 Year-67.87%
5 Year-50.53%

Profit Growth

1 Year98.67%
3 Year-158.15%
5 Year-162.28%

ROE%

1 Year-0.18%
3 Year-4.13%
5 Year-1.96%

ROCE %

1 Year-0.19%
3 Year-4.04%
5 Year-1.72%

Debt/Equity

0

Price to Cash Flow

25.33

Interest Cover Ratio

-33.8377558073144

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2022 50.13 0
Mar 2022 50.13 0.07
Dec 2021 50.13 0
Sep 2021 50.13 0
Jun 2021 50.14 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 0.0634606 Cr.
  • Company is virtually debt free.
  • Company has a healthy liquidity position with current ratio of 13.7762034015967.
  • The company has a high promoter holding of 50.13%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 8.24507276034289.

 Limitations

  • The company has shown a poor profit growth of -158.146690938806% for the Past 3 years.
  • The company has shown a poor revenue growth of -67.8672014629396% for the Past 3 years.
  • Company has a poor ROE of -4.12679116220983% over the past 3 years.
  • Company has a poor ROCE of -4.03631280065499% over the past 3 years
  • Company has high debtor days of 1249.0240280914.
  • The company has a low EBITDA margin of -27.0130659340729% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 11239.482.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022
Net Sales 0 0 0 0 0.01
Total Expenditure 0.08 0.07 0.35 0.07 0.12
Operating Profit -0.08 -0.07 -0.35 -0.07 -0.11
Other Income 0.01 0.02 0.44 0.14 0.01
Interest 0 0 0 0 0
Depreciation 0.05 0.05 0.05 -0.07 0.02
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.12 -0.11 0.03 0.14 -0.12
Tax 0 0 0 0.01 0
Profit After Tax -0.12 -0.11 0.03 0.13 -0.12
Adjusted EPS (Rs) -0.1 -0.09 0.02 0.1 -0.09

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Net Sales 22.76 22.35 21.62 10.91 0.74
Total Expenditure 21.99 21.92 21.66 19.98 1.26
Operating Profit 0.77 0.44 -0.04 -9.07 -0.51
Other Income 1.13 0.68 1.14 1.12 0.73
Interest 0.02 0.02 0.04 0.01 0
Depreciation 0.37 0.34 0.35 0.36 0.33
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.51 0.76 0.71 -8.32 -0.12
Tax 0.35 0.2 0.12 0.01 -0.01
Net Profit 1.16 0.56 0.59 -8.33 -0.11
Adjusted EPS (Rs.) 0.93 0.45 0.47 -6.68 -0.09

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 12.47 12.47 12.47 12.47 12.47
Total Reserves 53.9 54.45 55.04 47.38 48.5
Borrowings 0 0.12 0.06 0 0
Other N/C liabilities 1.44 1.6 1.7 0.68 0.56
Current liabilities 4.2 3.18 4.51 1.03 1.11
Total Liabilities 72.01 71.82 73.78 61.55 62.64
Assets
Net Block 3.88 3.93 3.91 3.63 3.26
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 45.32 45.72 46.95 45.47 44.1
Loans & Advances 0.41 0.44 0.45 0.05 0.05
Other N/C Assets 0 0 0 0 0
Current Assets 22.41 21.72 22.47 12.4 15.23
Total Assets 72.01 71.82 73.78 61.55 62.64
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations 1.51 0.76 0.71 -8.32 -0.12
Adjustment 0.37 0.34 0.35 0.94 1.57
Changes in Assets & Liabilities 1.15 -0.07 0.37 6.45 0.79
Tax Paid -0.33 -0.18 -0.1 0 0
Operating Cash Flow 2.7 0.86 1.33 -0.92 2.24
Investing Cash Flow -1.76 -0.96 -1.19 -0.4 -2.19
Financing Cash Flow 0 0.17 -0.05 -0.06 -0.06
Net Cash Flow 0.94 0.07 0.09 -1.38 -0.02

Corporate Actions

Investors Details

PARTICULARS Jun 2021% Sep 2021% Dec 2021% Mar 2022% Jun 2022%
Promoters 50.14 50.13 50.13 50.13 50.13
alok k. garg - - - - 0.56
alok k garg 0.56 0.56 0.56 0.56 -
r c mittal - - - - 25.39
ramesh chandra mit... 25.39 25.39 25.39 25.39 -
kusum mittal 21.65 21.69 21.69 21.69 0.08
manisha garg - - - - 21.61
trapti investments... - - 2.46 2.46 2.46
trapti investment ... 2.46 2.46 - - -
trapti investments... - - - - -
anantram daudayal ... 0.05 0.05 0.05 0.05 0.05
anantram daudayal ... - - - - -
nirmala anantram m... 0.02 0.02 0.02 0.02 0.02
nirmalal anantram ... - - - - -
PARTICULARS Jun 2021% Sep 2021% Dec 2021% Mar 2022% Jun 2022%
Investors 49.86 49.87 49.87 49.87 49.87
sangeetha s - - - 5.72 5.72
subramanian p 4.94 4.94 4.94 - -
subrmanian p - - - - -
babalbhai manilal ... 2.14 2.37 2.45 2.50 2.54
dipak kanayalal sh... 1.28 1.28 - 1.33 1.34
vijit ramavat - - - - -
dipak kanyalal shah - - 1.28 - -
shri parasram hold... - 1.09 - - -
shri parasram hold... - - - - -
shri parashram hol... 1.13 - - - -
vipin kumar jain - - 1.09 1.09 1.09
iepf 0.49 0.49 0.49 0.49 0.65

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Medi-Caps Stock Price Analysis and Quick Research Report. Is Medi-Caps an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a LOW P/E are undervalued (it depends on other factors too). Medi-Caps has a PE ratio of -825.497287522604 which is low and comparatively undervalued .

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Medi-Caps has ROA of -0.178419814644435 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Medi-Caps has a Current ratio of 13.7762034015967 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Medi-Caps has a ROE of -0.183406775082098 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Medi-Caps has a D/E ratio of 0 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Medi-Caps has an Inventory turnover ratio of 2.54855095161374 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Medi-Caps has reported revenue growth of -93.2013154667541 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Medi-Caps for the current financial year is -69.3008336568298 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Medi-Caps is Rs 0 and the yield is 0 %.

Brief about Medi-Caps

X